London, United Kingdom
Sanome is a UK-based startup that aims to revolutionize diagnostics in the healthcare industry with their slogan "Transforming diagnostics for all." Founded in 2021, Sanome addresses the escalating demand for healthcare services by focusing on early detection and prevention. Their innovative approach involves the development of a Clinical Co-pilot, which assists clinicians in identifying patient health changes at an early stage. This is achieved by leveraging healthcare data and translating it into actionable insights, supporting clinical decision-making.
What sets Sanome apart is their long-term vision of creating a human digital twin capable of comprehensively understanding an individual's health and providing crucial information to clinicians. The company's proprietary multimodal generative AI platform, their "secret sauce," translates diverse data streams into valuable clinical insights, seamlessly integrating with clinical workflows and IT systems.
The £2.00M Pre Seed Round investment on 28 September 2021 from a notable group of investors including Crista Galli Ventures, Heal Capital, o2h Ventures, Selvedge Venture, David Cleevely, Meltwind Advisory, and Pam Garside is a significant milestone for Sanome. This backing provides the company with the necessary resources to further develop their innovative solutions and propel their mission to transform healthcare diagnostics.
Sanome operates at the intersection of Biotechnology and Health Care, with a promising vision and strong support from the investment community, positioning the company as a potential game-changer in the healthcare industry.
